Macmillan virtual multi-disciplinary team (vMDT)
625,000 people experience long-term consequences following their cancer treatment. Some of these are complex in nature and may benefit from expert advice from a range of specialities.
Macmillan, in partnership with The Christie, have developed the Macmillan virtual MDT platform to facilitate this.
It is a secure online forum, providing quick and easy access to multi-specialist advice for complex or severe chronic symptoms following cancer treatment. Referrals to the vMDT will receive a response within two weeks, helping shared decision making regarding future care.
Health professionals who refer their patients to the vMDT can select which advice to follow and maintain responsibility for their patient throughout. The aim is to improve the outcomes and quality of life for people experiencing complex issues.
Referrals will be accepted from oncology for patients treated for:
- cancer in childhood through to young adulthood
- those who have undergone a bone marrow transplant
- those who have been treated for pelvic cancers with chemotherapy, radiotherapy or surgery.
By 2020, almost half of the population will get cancer at some point in their lives, but the proportion of people who survive will also continue to rise. This means that even more people will be living with the long-term effects of cancer and its treatment.
In 2013, a pilot of a virtual multi-disciplinary team (vMDT) was conducted with the University of Dundee to facilitate online MDT meetings for patients experiencing late effects following a diagnosis of cancer in childhood.
The conclusion from this was that the vMDT provided the opportunity for patients to receive personally tailored multi-disciplinary advice, regardless of the services and expertise available in their local area. This could be used to reduce geographical inequalities, while helping to ensure that the most appropriate, effective care is recommended for each and every patient.
For more information please email the Consequences of Treatment team.